Skip to content
Close menu

SBRI HEALTHCARE

Blueberry Therapeutics

Find a company

By exploiting a recently described nanoparticle based drug delivery system, Blueberry Therapeutics is developing a new treatment for patients with diabetic foot ulceration. This new concept allows a range of beneficial medicines to be incorporated into a hydrogel wound dressing. The new enhanced hydrogel dressings enable more effective infection control and promote wound healing in patients with diabetic foot ulcers.

Project Smart dressings for the treatment of diabetic foot ulcers
Description

By exploiting a recently described nanoparticle based drug delivery system, Blueberry Therapeutics is developing a new treatment for patients with diabetic foot ulceration. This new concept allows a range of beneficial medicines to be incorporated into a hydrogel wound dressing. The new enhanced hydrogel dressings enable more effective infection control and promote wound healing in patients with diabetic foot ulcers.

Funding £ 82,703
Competition Competition 8 - Improving the Care of the Diabetic Foot Ulcer: Better prevention, diagnosis, treatment
Competition Date October 2014
Categories Infection , Inflammatory & immune system , Diabetes
Health Innovation Network Partner Health Innovation Manchester
Website http://www.blueberrytherapeutics.com/

Subscribe

Subscribe to the SBRI Healthcare newsletter and receive the latest competition information & latest news updates.